基因工程细菌具有外套生物膜,用于增强药物输送到瘤中的基因工程细菌
Aiqing Ma1, Jiaxing Wang1,2, Weijian Song2
1Guangdong Provincial Key Laboratory of Natural Drugs Research and Development, The Second Affiliated Hospital, Guangdong Medical University, Dongguan, 523808, China.
Materials today. Bio
|January 21, 2026
概括
基因工程细菌创造了一种保护性的生物膜"外套",以防止药物过早释放. 这提高了瘤向治疗的药物输送和疗效,改善了细菌瘤学的结果.
科学领域:
- 生物技术是生物技术.
- 微生物学 微生物学
- 在瘤学瘤学.
背景情况:
- 瘤向细菌是有前途的药物载体,因为其运动性和缺氧-homing.
- 从细菌载体中提前释放药物会降低疗效,增加毒性.
研究的目的:
- 开发一种基因工程策略,利用细菌增强瘤向药物输送.
- 在细菌上制造生物膜涂层,以防止药物过早释放并改善药物吸附.
主要方法:
- 通过基因工程 *E. coli* MG1655 (EC) 通过调节Csg基因集群来产生表面生物膜外套 (MEC).
- 从MEC与EC相比,评估了药物吸附和释放的绿色氨酸 (ICG).
- 在小鼠瘤模型中评估了MEC的瘤定位能力,药物输送,保留和光热疗效.
主要成果:
- 生物膜涂层 (MEC) 将ICG吸附率提高了1.7倍,并防止了目标外泄漏.
- 与EC相比,MEC在瘤内部地区提供了显著更多的ICG.
- 经MEC介导的输送导致了增强的内药物保留和光热疗效 in vivo.
结论:
- 基因工程生物膜技术为瘤向药物输送提供了有效的策略.
- MEC增强了药物吸附,防止过早释放,并提高了细菌瘤学的治疗疗效.
- 这种方法为精准医学在癌症治疗中提供了一个有希望的途径.
相关概念视频
What is Genetic Engineering?
79.7K
Overview
79.7K
Bioavailability Enhancement: Drug Solubility Enhancement
226
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
226
Bioavailability Enhancement: Drug Permeability Enhancement
193
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
193
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
202
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
202
Drug Delivery: Overview
750
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
750
Drug Delivery: Enteral Route
1.6K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.6K


